Search

everythinglearnresearchcommunity

for

Search:↓

Low vitamin D levels are common in people with Alopecia Areata.

Modified superoxide dismutase may trigger an autoimmune response in alopecia areata.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

Certain gene variations increase the risk of alopecia areata in Koreans.

Trichoscopy helps better understand and manage alopecia areata, improving patient outcomes.

Certain proteins involved in DNA modification may affect the genetic changes in systemic lupus erythematosus and could indicate the disease's activity.

Hair loss can be reversed or even cured using advanced hair restoration techniques, with rare complications like swelling and bleeding.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Alopecia areata in US adolescents leads to significant healthcare costs and usage.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

Minoxidil, a common alopecia medication, might cause eye changes due to its properties and lack of tissue selectivity.

Immunization and throat bacteria may increase the risk of a hair loss condition called alopecia areata.

More research is needed on alopecia areata treatments and its psychological effects.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Alopecia frontal fibrosante affects facial vellus hair and can be diagnosed with dermatoscopy.

DDS treatment for LABD can cause severe side effects like anemia and hair loss, requiring careful monitoring.

Reflectance confocal microscopy is a promising non-invasive tool for diagnosing alopecia areata incognita.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Vitamin D receptor gene changes don't affect alopecia areata risk.

Personality traits significantly affect the onset, progression, and psychological impact of alopecia areata.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Low vitamin D levels may worsen or cause alopecia areata.

Alopecia areata is increasing globally, with disparities needing better prevention and support.

Restoring microbial balance and using exosome therapies may help treat hair disorders like alopecia and acne.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

Anti-CD19 therapy may help treat SLE and NMOSD.